August 17, 2026 09:16 am (IST)
Follow us:
Dahej plant of Torrent Pharma receives USFDA approval
Ahmedabad/Mumbai, Mar 18 (IBNS) Torrent Pharma, a leading Indian pharma company, informed on Friday that it has obtained the Establishment Inspection Report from the U.S. Food and Drug Administration (USFDA) for its plant located at Dahej SEZ, Gujarat.
The company had set up the plant mainly to cater to the regulated international markets such as US, Germany, Brazil, etc.
Prior to the US approval, the plant had received approval from EU Germany.
The Dahej plant is spread across 70 acres of land with a built up area of about 97000 sq meter. Phase 1 has an installed capacity to manufacture 7,500 million tablets/capsules and 25 MT API per annum.
The company has said that construction of Phase 2 will commence soon. After commission, the total capacity will increase to manufacture of 14,000 million tablets/capsules and 80 MT API per annum.
In their filing with the National Stock Exchang, the company has said that with the approval of the Dahej plant, three of its five plants have received USFDA approval.
The other two plants are located at Indrad (Gujarat) and Pithampur, Indore (Madhya Pradesh).
The company's share price moved up during trading hours on Friday following the news of the approval
Torrent Pharma is a flagship company of the Torrent Group.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Mahindra launches BLAZO i-TRK: All details inside
Sun, Aug 16 2026
Reliance Industries, Rolls-Royce join hands to explore indigenous engine for India’s AMCA fighter
Sat, Aug 15 2026
BSNL’s Independence Day gift: Re 1 Recharge, 412-Day Plan and 500 Free TV Channels. Check now
Sat, Aug 15 2026
Emami’s big snack bet: ₹750 crore investment, new WeMe brand targets ₹1,000 crore in 3-5 years
Sat, Aug 15 2026
HCG Q1 results: Cancer care major posts 190% jump in adjusted profit, revenue rises 13%
Fri, Aug 14 2026
Big relief for Zee Entertainment: SAT allows warrants issue, dividend access despite SEBI ban
Fri, Aug 14 2026
Olectra Greentech Q1 shocker: Revenue soars 66%, profit barely moves; shares crash 4%
Fri, Aug 14 2026
Red Friday on Dalal Street: Sensex plunges 300 points, Nifty slides amid geopolitical tensions
Fri, Aug 14 2026
Tata Motors shares jump 6% after Q1 profit soars 83% to ₹2,560 crore
Thu, Aug 13 2026